Councils - Junior Faculty and Trainee
Scientific Council for Junior Faculty & Trainees Council Leadership Operating Board:COUNCIL CHAIR: NOT A COUNCIL MEMBER?
Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website
where you can update your membership profile and join any of the 11 Scientific Councils.
Wednesday, April 15, 2015, 12:45 PM - 1:45 PM
Acropolis Congres Centre, Nice, FRANCE
The goal of the is to provide an opportunity for trainees to meet with an established specialist in their respective field in order to facilitate communication and gain guidance, and provide an opportunity for academic career enrichment.
The ISHLT Mentorship Program will be available to all ISHLT members via ISHLTConnect
, our Online Community, in April 2015. (This program is only available to current ISHLT members.)
Allegheny General Hospital
Pittsburgh, Pennsylvania, USA
firstname.lastname@example.orgManreet Kanwar, MD, FACC, is an Assistant Professor of Medicine at Temple University School of Medicine. She completed her residency in Internal Medicine in 2007, followed by a fellowship in Cardiovascular Diseases at St John Hospital and Medical Center in Detroit, Michigan. In 2010, she joined the Advanced Heart Failure, Pulmonary Hypertension and Cardiac Transplant fellowship program at Allegheny General Hospital, Pittsburgh, where she continued on as faculty since July 2011. Her clinical interests include care of patients with end stage heart failure, mechanical circulatory support, pulmonary hypertension and cardiac transplantation. Her research interests include pulmonary hypertension secondary to left heart disease as well as improving patient outcomes in mechanical support devices.COUNCIL VICE CHAIR:
David Geffen School of Medicine
Los Angeles, California, USA
email@example.comDr. DePasquale received his M.D. degree from State University of New York, Downstate College of Medicine. He completed his Internal Medicine Residency, Fellowship in Cardiovascular Medicine, and a Fellowship in Advanced Heart Failure and Transplant Cardiology at the Yale-New Haven Hospital. At the same institution, he was Chief Cardiology Fellow, and completed an additional Fellowship with a focus in Inherited Cardiomyopathies with additional study at University College London. Dr. DePasquale currently serves as an Associate Director - Outpatient Heart Transplantation for the UCLA Advanced Heart Failure, Heart Transplantation and Mechanical Circulatory Support Programs.COUNCIL VICE CHAIR-ELECT
Virginia Commonwealth University
Richmond, VA, USA
firstname.lastname@example.orgDr. Shah is an Assistant Professor in the Division of Cardiology at Virginia Commonwealth University Hospital System (formerly Medical College of Virginia) in Richmond, VA. Dr. Shah completed both his residency in internal medicine and fellowship training at the University of Maryland, Baltimore, MD. Dr. Shah’s clinical interests include heart failure, heart transplantation, pulmonary hypertension and mechanical circulatory support. He is the Medical Director of the Mechanical Circulatory Support Program at VCU.COUNCIL PAST CHAIR:
St Vincent Heart Center
Indianapolis, Indiana, USAjennifercowger@gmail.comJennifer Cowger, MD, MS, is a clinical lecturer in Cardiovascular Medicine. Her expertise is in advanced heart failure, cardiac transplant, and mechanical support of the heart. Dr. Cowger received her medical degree from the Ohio State University, graduating class valedictorian in 2001. She completed her Internal Medicine Residency at Duke University Medical Center in Durham, North Carolina in 2004. She received her Cardiovascular Medicine Fellowship training at the University of Michigan with subspecialty training in Heart Failure and Cardiac Transplant which was completed in 2007. After concluding her medical education, Dr. Cowger obtained a Masters in Clinical Research and Statistics at the University's School of Public Health. Dr. Cowger's research interests are in mechanical circulatory support of the heart using left ventricular assist devices (LVADs). Her specific research area of focus is on imporving patient outcomes with long term LVAD support. She is also interested in investigating novel means of reducing oxidative stress in the setting of heart failure.BOARD OF DIRECTORS LIAISON
St. Vincent's Hospital
email@example.comProfessor Glanville trained in Sydney, Brompton Hospital, London and Stanford University, California. Currently working as a specialist in Lung Transplantation at St. Vincent's Hospital Sydney, he is actively involved with international trials into new immunosuppressive and anti-viral agents. He is Global Principal Investigator for the European and Australian Investigators in Lung Transplantation CeMyLungs trial, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He has authored over 140 publications including approaches to antibody mediated rejection, bronchoscopic surveillance, RSV, CMV, Chlamydia and mycobacteria. He is the senior author of the International Guidelines for Lung Transplantation, foundation director of Outcomes Australia and a foundation member of ShareLife Australia.COUNCIL WORKFORCE LEADERS:
Rochester, Minnesota, USA
firstname.lastname@example.orgJonathan Johnson, MD is an associate professor of Pediatrics at the Mayo Clinic in Rochester, Minnesota, where he is the medical director of the Pediatric Heart Transplant Program. Dr. Johnson received his medical degree from Wayne State University in 2005. He completed training in Pediatric and Adolescent Medicine at the Mayo Clinic in 2008, and subsequently went on to complete subspecialty training in Pediatric Cardiology at Mayo in 2011. Dr. Johnson’s research interests focus on improving clinical outcomes of pediatric heart failure and transplant patients, the use of mTOR inhibitors in the pediatric population, and on novel methods to non-invasively detect allograft rejection. He also serves as co-director of CME programs for the Department of Pediatrics at the Mayo Clinic, and has a particular interest in symposium and meeting development.
University of Michigan Cardiovascular
Ann Arbor, Michigan, USA
email@example.comBio coming soon...
Mayo Clinic Arizona
Scottsdale, AZ, USA
firstname.lastname@example.orgEvan Kransdorf is a senior fellow in Cardiovascular Diseases at Mayo Clinic Arizona and an Instructor in Medicine at the Mayo Clinic Medical School. Evan received a combined MD/PhD degree from the Virginia Commonwealth University School of Medicine, and then completed residency in internal medicine at Duke University Medical Center. He then completed a fellowship in Advanced Heart Failure and Heart Transplantation at Cedars-Sinai Medical Center. His clinical and research interests include Chagas and genetic cardiomyopathies, donor-recipient matching in heart transplantation, and cardiac allograft vasculopathy.
Loyola University Medical Center
Maywood, Illinois, USA
The Proof Centre of Excellence
email@example.comZsuzsanna Hollander is currently pursuing a PhD at UBC, Department of Pathology and Laboratory Medicine, under the supervision of Dr. Bruce McManus. Her work focuses on identifying novel biomarkers for the management of heart failure and heart transplant patients. Zsuzsa obtained a Master’s of Science degree in Computer Science from the University of British Columbia, Vancouver. She is also a certified Project Management Professional (PMP). Zsuzsa started working for the Biomarkers in Transplantation project in 2004 and transferred to the PROOF Centre of Excellence in 2008. She has expertise in genomics, proteomics and metabolomics data analyses as well as bioinformatics and data management.
University of California San Diego
San Diego, California, USA
firstname.lastname@example.orgBio coming soon...
Inova Fairfax Hospital
Falls Church, Virginia, USA
email@example.comPalak Shah, MD, MS is a researcher and transplant Cardiologist at Inova Fairfax Hospital. Dr. Shah’s clinical interests include advanced cardiomyopathies, mechanical circulatory support and cardiac transplantation. He received his undergraduate training from Carnegie Mellon University and medical degree from St. George’s University in 2005. He subsequently completed residency in Internal Medicine at Georgetown University. In 2009, he spent a year as Chief Medical Resident at Georgetown University. During his Cardiovascular Disease Fellowship at George Washington University he received a Masters in Clinical and Translational Research and was also elected into the Alpha Omega Alpha honors society. Dr. Shah received his Heart Failure and Cardiac Transplant training at the University of Michigan in 2012. His research interests are focused in mechanical circulatory support; more specifically use of genomic tools to better predict and manage the complications of VAD therapy.
Indiana University Health
Indianapolis, IN, USAmcaccamo@iuhealth.orgMarco Caccamo, DO, is an Assistant Professor of Medicine at Indiana University School of Medicine. He completed his residency training at the Cleveland Clinic in 2009. Dr. Caccamo then moved to Minneapolis, Minnesota where he completed his cardiology training at the University of Minnesota in 2012. He then completed an additional year in advanced heart failure and pulmonary hypertension at Allegheny General Hospital in Pittsburgh, PA. His clinical interests include pulmonary hypertension, mechanical circulatory support and cardiac transplantation.
University Hospital Gasthuisberg
firstname.lastname@example.orgRobin Vos, MD, PhD, is Assistant Professor of Pulmonary Medicine at the Katholieke Universiteit and University Hospital Gasthuisberg, Leuven, Belgium. He obtained his undergraduate degree in Medicine at the Faculty of Medicine, Katholieke Universiteit Leuven, Belgium in 2004, after which he completed his Residency in Internal and Pulmonary Medicine at the University Hospital Gasthuisberg, Leuven, Belgium in 2012. From 2006 until 2010 he performed his PhD fellowship in the lab of Pneumology, Katholieke Universiteit Leuven, Belgium under the supervision of Prof. dr. GM. Verleden. His clinical and research interests include the pathophysiology and treatment of acute and chronic lung allograft rejection.